HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

NeurologyLive® Friday 5 — December 3, 2021

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 3, 2021.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Treatment Planning and Shared Decision-Making in RRMS

In episode 3 of this NeurologyLive® Peer Exchange, "Oral Therapy Options for Relapsing-Remitting Multiple Sclerosis," Jennifer Graves, MD, PhD, MAS; Suma Shah, MD; and Gabrielle Macaron, MD, discuss best practices for talking about treatment goals and options with patients who have relapsing-remitting multiple sclerosis.

2: Podcast Episode 52: Treating Pediatric Migraine

Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Christina Szperka, MD, MSCE, who offered up her thoughts on the current state of clinical care and awareness of pediatric migraine and shared her insight into the changes the landscape of treatment has undergone.

3: NeuroVoices: Jeffrey Cummings, MD, ScD, on Evaluating Alzheimer Trial Funding, Eliminating Wasteful Costs

The director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada–Las Vegas discussed his recently published research on the costs of developing treatments for Alzheimer disease, providing background on the reason for the analysis, how the clinician community should react to the data, and ways to eliminate drug failures.

4: Future Integration, Coverage for Telemedicine in Multiple Sclerosis: Marisa McGinley, DO

The staff neurologist at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic discussed the necessary data required to support telemedicine’s full integration into regular clinical care for patients with multiple sclerosis.

5: Advancing a New Era for Parkinson Disease: Cleveland Clinic’s Palliative Care Approach

As more organizations begin to adopt palliative care practices for patients with Parkinson disease, some may turn to the implemented plans of Cleveland Clinic as an example to follow. This addition to our Gold Standard Centers series offers an inside look into the Cleveland Clinic Palliative Care Clinic.

Introducing: Giants of Multiple Sclerosis™

Recognize and celebrate the individuals who have achieved landmark successes within multiple sclerosis! Giants of Multiple Sclerosis™ is a premier neuroscience award that celebrates pioneers, innovators, and future generations of leaders who have been selected by their peers for their remarkable achievements in Multiple Sclerosis.

Nominate Someone Today for a 2022 Giants of Multiple Sclerosis™ Award

  • Nominations are open through January 31, 2022
  • The Giants of Multiple Sclerosis™ Steering Committee will vet all nominations and vote to determine the 2022 inductees
  • Nominees will be selected on the merits of their lifetime work.
  • One honoree in each category who makes a measurable difference in the lives of patients will be awarded.
  • The 2022 Giants of Multiple Sclerosis™ inaugural class will be announced in Spring of 2022

Nominate someone here.